Companies / Nuvation Bio Inc.

Nuvation Bio Inc.

NYSE: NUVBCIK 1811063NEW YORK, NY

Financials · FY2025

Revenue$62.90M
Net income$-204.63M
Total debt$248.52M
Cash$258.60M
Diluted EPS$-0.60
Shares outstanding351.1M

Ownership

351.1M shares outstanding · as of Aug 3, 2026
61.9%Institutions
Ownership
Institutions61.90%217,340,484
Public float38.10%133,782,749

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 13

View all →
Insider% of sharesShares
Makunje MosesFormerSEE REMARKS
0.02%68,137
Wentworth KerryFormerCHIEF REGULATORY OFFICER
0.02%53,000
Cui XiangminFormerDirector
Hanley David C.FormerCHIEF TECHNICAL OPERATIONS
Hattersley GaryCHIEF SCIENTIFIC OFFICER
Hung DavidCEOPRESIDENT AND CEO · Director · 10% owner
Liu DongfangFormerCHIEF MEDICAL OFFICER
Markel StacyFormerCHIEF PEOPLE OFFICER

Institutional holders 234

View all →
HolderValue% of shares
Fmr LLC$460.77M14.65%
Decheng Capital LLC$232.55M7.39%
BlackRock, Inc.$156.94M7.87%
Vanguard Group Inc$139.38M4.43%
Omega Fund Management, LLC$72.41M2.30%
State Street Corporation$41.87M2.10%
Bank of America Corp /De$34.13M1.08%
Laurion Capital Management LP$33.56M2.23%
Redmile Group, LLC$28.34M0.90%
Nuveen, LLC$25.55M0.81%

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Apr 6, 2026Wentworth Kerry
Executive
SellClass A Common Stock$903.6K-200K
-79.05%
53,000
0.02% of shares
medium
Jun 23, 2026Wentworth Kerry
Executive
SellClass A Common Stock$379.2K-63K
-54.31%
53,000
0.02% of shares
medium
Apr 6, 2026Wentworth Kerry
Executive
ExerciseClass A Common Stock$194.0K+100K
+65.36%
253,000
0.07% of shares
low
Apr 6, 2026Wentworth Kerry
Executive
ExerciseClass A Common Stock$187.0K+100K
+188.68%
153,000
0.04% of shares
low
Jun 23, 2026Wentworth Kerry
Executive
ExerciseClass A Common Stock$184.6K+63K
+118.87%
116,000
0.03% of shares
low
Apr 17, 2026Wentworth Kerry
Executive
SellClass A Common Stock$184.3K-37K
-40.95%
53,000
0.02% of shares
medium
Apr 17, 2026Wentworth Kerry
Executive
ExerciseClass A Common Stock$107.7K+37K
+69.34%
89,750
0.03% of shares
low
Feb 27, 2026Makunje Moses
Executive
GrantClass A Common Stock$0+51K
+292.13%
68,137
0.02% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
NUVBCommon StockEquity67080N101BBG00VHJ0CC1